Chris Reinhard is Founder and Chief Executive Officer of Gene Biotherapeutics. For almost 20 years, Mr. Reinhard has focused on the commercial development of cardiovascular growth factor therapeutics. Mr. Reinhard also served as Executive Chairman of Artes Medical from 2004 to 2008, and was Vice President and Managing Director of the Henley Group, and Vice President of various public and private companies created by the Henley Group through spin-out transactions, including Fisher Scientific Group. Mr. Reinhard received a B.S. in Finance and an M.B.A. from Babson College.